Literature DB >> 12396457

Immunologic profile of highly exposed yet HIV type 1-seronegative men.

Otto O Yang1, W John Boscardin, Jose Matud, Mary Ann Hausner, Lance E Hultin, Patricia M Hultin, Roger Shih, John Ferbas, Frederick P Siegal, Michael Shodell, Gene M Shearer, Edith Grene, Mary Carrington, Steve O'Brien, Charles B Price, Roger Detels, Beth D Jamieson, Janis V Giorgi.   

Abstract

The host immune factors that determine susceptibility to HIV-1 infection are poorly understood. We compared multiple immunologic parameters in three groups of HIV-1-seronegative men: 14 highly exposed (HR10), 7 previously reported possibly to have sustained transient infection (PTI), and a control group of 14 low risk blood bank donors (BB). Virus-specific cellular immune assays were performed for CD4(+) T helper cell responses, CD8(+) cytotoxic T lymphocyte activity, CD8(+) cell chemokine release, and CD8(+) cell-derived antiviral soluble factor activity. General immune parameters evaluated included CCR5 genotype and phenotype, interferon alpha production by PBMCs, leukocyte subset analysis, and detailed T lymphocyte phenotyping. Comparisons revealed no detectable group-specific differences in measures of virus-specific immunity. However, the HR10 group differed from the BB group in several general immune parameters, having higher absolute monocyte counts, higher absolute CD8(+) T cell counts and percentages, lower naive and higher terminal effector CD8(+) cells, and lower levels of CD28(+)CD8(+) cells. These changes were not associated with seropositivity for other chronic viral infections. The PTI men appeared to have normal levels of monocytes and slightly elevated levels of CD8(+) T cells (also with increased effector and decreased naive cells). Although we cannot entirely exclude the contribution of other chronic viral infections, these findings suggest that long-lived systemic cellular antiviral immunity as detected by our assays is not a common mechanism for resistance to infection, and that resistance may be multifactorial. General immune parameters reflected by CD8(+) T cell levels and activation, and monocyte concentrations may affect the risk of infection with HIV-1, and/or serve as markers of exposure.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12396457     DOI: 10.1089/08892220260235416

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  12 in total

1.  Fine-tuning of T-cell receptor avidity to increase HIV epitope variant recognition by cytotoxic T lymphocytes.

Authors:  Michael S Bennett; Aviva Joseph; Hwee L Ng; Harris Goldstein; Otto O Yang
Journal:  AIDS       Date:  2010-11-13       Impact factor: 4.177

2.  Human immunodeficiency virus type 1 clade B superinfection: evidence for differential immune containment of distinct clade B strains.

Authors:  Otto O Yang; Eric S Daar; Beth D Jamieson; Arumugam Balamurugan; Davey M Smith; Jacqueline A Pitt; Christos J Petropoulos; Douglas D Richman; Susan J Little; Andrew J Leigh Brown
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 3.  Understanding the "lucky few": the conundrum of HIV-exposed, seronegative individuals.

Authors:  Barbara L Shacklett
Journal:  Curr HIV/AIDS Rep       Date:  2006-02       Impact factor: 5.071

4.  Genetic and stochastic influences on the interaction of human immunodeficiency virus type 1 and cytotoxic T lymphocytes in identical twins.

Authors:  Otto O Yang; Joseph Church; Christina M R Kitchen; Ryan Kilpatrick; Ayub Ali; Yongzhi Geng; M Scott Killian; Rachel Lubong Sabado; Hwee Ng; Jeffrey Suen; Yvonne Bryson; Beth D Jamieson; Paul Krogstad
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  Highly Human Immunodeficiency Virus-Exposed Seronegative Men Have Lower Mucosal Innate Immune Reactivity.

Authors:  Jennifer A Fulcher; Laura Romas; Jennifer C Hoffman; Julie Elliott; Terry Saunders; Adam D Burgener; Peter A Anton; Otto O Yang
Journal:  AIDS Res Hum Retroviruses       Date:  2017-06-19       Impact factor: 2.205

6.  Differences in T cell distribution and CCR5 expression in HIV-positive and HIV-exposed seronegative persons who inject drugs.

Authors:  Eveli Kallas; Kristi Huik; Silver Türk; Merit Pauskar; Ene-Ly Jõgeda; Marina Šunina; Tõnis Karki; Don Des Jarlais; Anneli Uusküla; Radko Avi; Irja Lutsar
Journal:  Med Microbiol Immunol       Date:  2015-12-22       Impact factor: 3.402

7.  T Cell Distribution in Relation to HIV/HBV/HCV Coinfections and Intravenous Drug Use.

Authors:  Eveli Kallas; Kristi Huik; Silver Türk; Merit Pauskar; Ene-Ly Jõgeda; Marina Šunina; Tõnis Karki; Don Des Jarlais; Anneli Uusküla; Radko Avi; Irja Lutsar
Journal:  Viral Immunol       Date:  2016-08-26       Impact factor: 2.257

8.  The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities.

Authors:  Zuzana Keckesova; Laura M J Ylinen; Greg J Towers
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

9.  Primary human immunodeficiency virus type 1 (HIV-1) infection during HIV-1 Gag vaccination.

Authors:  Arumugam Balamurugan; Martha J Lewis; Christina M R Kitchen; Michael N Robertson; John W Shiver; Eric S Daar; Jacqueline Pitt; Ayub Ali; Hwee L Ng; Judith S Currier; Otto O Yang
Journal:  J Virol       Date:  2008-01-16       Impact factor: 5.103

10.  Associations between virologic and immunologic dynamics in blood and in the male genital tract.

Authors:  Sara Gianella; Matthew C Strain; Steffney E Rought; Milenka V Vargas; Susan J Little; Douglas D Richman; Celsa A Spina; Davey M Smith
Journal:  J Virol       Date:  2011-11-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.